Year archive

CHIMERIC THERAPEUTICS LIMITED — 2021 filings

All 76 regulatory filings released by CHIMERIC THERAPEUTICS LIMITED (CHM) in 2021, sourced directly from the official regulator.

76 Filings

2021 Period

2021 filings (76)

Filing	Released	Lang
Successful completion of 2nd dose cohort in CLTX CAR T trial 3 pages 266.1KB Regulatory Filings	2021-12-16	English
Change of Director's Interest Notice - JC, CE & GM 8 pages 449.9KB Director's Dealing	2021-12-13	English
Key management changes for 2022 3 pages 177.9KB Board/Management Information	2021-12-12	English
Change of Director's Interest Notice - PH 3 pages 183.0KB Director's Dealing	2021-12-07	English
Change in substantial holding - PH 3 pages 216.6KB Major Shareholding Notification	2021-12-07	English
CORE-NK CELL PLATFORM (supplementary announcement) 2 pages 169.4KB Capital/Financing Update	2021-12-06	English
Application for quotation of securities - CHM 7 pages 29.4KB Share Issue/Capital Change	2021-12-05	English
Application for quotation of securities - CHM 6 pages 28.3KB Capital/Financing Update	2021-12-02	English
Notification regarding unquoted securities - CHM 15 pages 50.6KB Share Issue/Capital Change	2021-12-02	English
Webinar CHM Transforms Portfolio 4 pages 276.1KB Capital/Financing Update	2021-11-30	English
Transformative Portfolio Expansion Presentation 26 pages 6.4MB Investor Presentation	2021-11-30	English
CLTX CAR T data shows regional control of tumour recurrence 4 pages 295.6KB Regulatory Filings	2021-11-21	English
AGM Presentation 18 pages 1.9MB AGM Information	2021-11-21	English
Results of Meeting 2 pages 305.0KB Declaration of Voting Results & Voting Rights Announcements	2021-11-21	English
CLTX CAR T PRESENTS POSITIVE INITIAL PHASE 1 CLINICAL DATA 4 pages 292.5KB Regulatory Filings	2021-11-14	English
FIRST MILESTONE ON PATH TO CDH17 CAR T CLINICAL TRIAL 2 pages 222.7KB Regulatory Filings	2021-10-21	English
Quarterly Activities/Appendix 4C Cash Flow Report 13 pages 1.8MB Interim / Quarterly Report Q1 2022	2021-10-20	English
Notice of Annual General Meeting/Proxy Form 34 pages 1.2MB AGM Information	2021-10-17	English
CHM 1101 data accepted for presentation at SNO meeting 2 pages 254.5KB Regulatory Filings	2021-09-28	English
Annual Report to shareholders 78 pages 8.1MB Annual Report FY 2021	2021-09-28	English
Appendix 4G 12 pages 263.4KB Regulatory Filings	2021-09-28	English
Corporate Governance Statement 7 pages 190.2KB Governance Information	2021-09-28	English
European patent granted for CLTX technology used in CHM 1101 2 pages 205.7KB Regulatory Filings	2021-09-22	English
Notification regarding unquoted securities - CHM 7 pages 29.9KB Share Issue/Capital Change	2021-09-22	English
Cellular therapy experts join Chimeric CI-SAB 3 pages 204.9KB Board/Management Information	2021-09-14	English
Initial Director's Interest Notice - JC 2 pages 168.9KB Director's Dealing	2021-09-01	English
Partnership with OncoBay Clinical to advance CHM 1101 2 pages 221.2KB Regulatory Filings	2021-09-01	English
Preliminary Final Report 32 pages 233.5KB Annual Report FY 2021	2021-08-30	English
Notice under section 708A 1 page 157.4KB Regulatory Filings	2021-08-30	English
Chimeric Appoints Jennifer Chow as CEO & MD 3 pages 231.6KB Board/Management Information	2021-08-29	English
Application for quotation of securities - CHM 9 pages 33.0KB Share Issue/Capital Change	2021-08-26	English
Notification regarding unquoted securities - CHM 9 pages 37.1KB Share Issue/Capital Change	2021-08-26	English
Release of ordinary shares from escrow 1 page 158.8 Share Issue/Capital Change	2021-08-24	English
Application for quotation of securities - CHM 6 pages 27.6KB Share Issue/Capital Change	2021-08-24	English
IND clearance received from US FDA for CHM 1101 2 pages 221.2KB Regulatory Filings	2021-08-19	English
Change of Director's Interest Notice - GM 2 pages 218.7KB Director's Dealing	2021-08-08	English
Dr Yi Lin appointed to Cellular Immunotherapy SAB 2 pages 220.8KB Board/Management Information	2021-08-05	English
Chimeric licenses novel solid tumor CAR T therapy from Penn 3 pages 255.8KB Capital/Financing Update	2021-07-27	English
Chimeric Therapeutics CDH17 Investor Webinar 2 pages 192.4KB Investor Presentation	2021-07-27	English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 330.6KB Interim / Quarterly Report Q4 2021	2021-07-26	English
Celgene Veteran Dr George Matcham Appointed to Board 2 pages 143.1KB Board/Management Information	2021-07-04	English
Initial Director's Interest Notice - GM 2 pages 181.2KB Director's Dealing	2021-07-04	English
Dr Li Ren Joins as Vice President Technical Operations 2 pages 165.5KB Board/Management Information	2021-06-24	English
Second Dose Cohort Initiated in CLTX CAR T Phase 1 Trial 2 pages 186.6KB Regulatory Filings	2021-05-23	English
Proposed issue of Securities - CHM 5 pages 27.4KB Capital/Financing Update	2021-05-04	English
Appendix 2A and 708A Notice 16 pages 459.5KB Regulatory Filings	2021-05-04	English
CLTX CAR T Abstract Accepted for Presentation at ASCO 2 pages 153.4KB Regulatory Filings	2021-05-02	English
Appendix 4C - quarterly 9 pages 370.6KB Interim / Quarterly Report Q1 2021	2021-04-22	English
Successful Completion of First Patient Cohort Phase 1 Trial 2 pages 148.3KB Regulatory Filings	2021-04-21	English
Successful Completion of Dosing in First Patient Cohort 2 pages 143.9KB Capital/Financing Update	2021-03-17	English
Investor Presentation 20 pages 3.2MB Investor Presentation	2021-03-17	English
Chimeric to Present at NWR Virtual Investor Conference 2 pages 119.2KB Investor Presentation	2021-03-16	English
Change of Director's Interest Notice - CE 2 pages 184.3KB Director's Dealing	2021-03-09	English
Half Yearly Report and Accounts 31 pages 2.5MB Interim / Quarterly Report H1 2021	2021-02-25	English
Dr Bourk former KITE PHARMA Senior Executive Joins Chimeric 2 pages 125.7KB Board/Management Information	2021-02-22	English
Initial Director's Interest Notice (Amended) - PH 2 pages 169.3KB Director's Dealing	2021-02-07	English
Change of Director's Interest Notice - LC 2 pages 184.7KB Director's Dealing	2021-02-01	English
Former Juno Executive Cindy Elkins Joins Chimeric Board 2 pages 133.5KB Board/Management Information	2021-01-31	English
Initial Director's Interest Notice - CE 2 pages 182.3KB Director's Dealing	2021-01-31	English
Dr Yvonne Chen Appointed to CHM Scientific Advisory Board 2 pages 98.4KB Board/Management Information	2021-01-28	English
Change of Director's Interest Notice - LC 2 pages 183.4KB Director's Dealing	2021-01-20	English
Initial Director's Interest Notice - LR 2 pages 201.0KB Director's Dealing	2021-01-18	English
Initial Director's Interest Notice - LC 2 pages 200.3KB Director's Dealing	2021-01-18	English
Initial Director's Interest Notice - PH 2 pages 187.9KB Director's Dealing	2021-01-18	English
Becoming a substantial holder - PH 3 pages 180.9KB Major Shareholding Notification	2021-01-18	English
Appendix 1A and Information Form and Checklist 19 pages 388.2KB Regulatory Filings	2021-01-17	English
Prospectus 136 pages 3.9MB Capital/Financing Update	2021-01-17	English
Constitution 55 pages 532.9KB Governance Information	2021-01-17	English
Annual Report 30 June 2020 25 pages 731.5KB Annual Report FY 2020	2021-01-17	English
Omnibus Incentive Plan Rules 28 pages 434.0KB Governance Information	2021-01-17	English
Securities Trading Policy 5 pages 535.0KB Governance Information	2021-01-17	English
Distribution Schedule 1 page 113.3KB Major Shareholding Notification	2021-01-17	English
Top 20 Holders 2 pages 123.5KB Major Shareholding Notification	2021-01-17	English
Pre-Quotation Disclosure 3 pages 142.2KB Capital/Financing Update	2021-01-17	English
Chimeric Therapeutics Commences Trading on the ASX 3 pages 143.8KB Capital/Financing Update	2021-01-17	English
ASX Market Release - Admission and Quotation 2 pages 459.3KB Capital/Financing Update	2021-01-14	English